Correlation Between Blueprint Medicines and Immuneering Corp
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Immuneering Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Immuneering Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Immuneering Corp, you can compare the effects of market volatilities on Blueprint Medicines and Immuneering Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Immuneering Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Immuneering Corp.
Diversification Opportunities for Blueprint Medicines and Immuneering Corp
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Immuneering is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Immuneering Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immuneering Corp and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Immuneering Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immuneering Corp has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Immuneering Corp go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Immuneering Corp
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.43 times more return on investment than Immuneering Corp. However, Blueprint Medicines Corp is 2.32 times less risky than Immuneering Corp. It trades about 0.05 of its potential returns per unit of risk. Immuneering Corp is currently generating about 0.01 per unit of risk. If you would invest 5,019 in Blueprint Medicines Corp on August 24, 2024 and sell it today you would earn a total of 4,396 from holding Blueprint Medicines Corp or generate 87.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Immuneering Corp
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Immuneering Corp |
Blueprint Medicines and Immuneering Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Immuneering Corp
The main advantage of trading using opposite Blueprint Medicines and Immuneering Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Immuneering Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuneering Corp will offset losses from the drop in Immuneering Corp's long position.| Blueprint Medicines vs. Lyra Therapeutics | Blueprint Medicines vs. Hookipa Pharma | Blueprint Medicines vs. Cingulate Warrants | Blueprint Medicines vs. SAB Biotherapeutics |
| Immuneering Corp vs. Pmv Pharmaceuticals | Immuneering Corp vs. Cullinan Oncology LLC | Immuneering Corp vs. Enliven Therapeutics | Immuneering Corp vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |